PE68199A1 - Composicion farmaceutica de residencia gastrica - Google Patents
Composicion farmaceutica de residencia gastricaInfo
- Publication number
- PE68199A1 PE68199A1 PE1998000281A PE00028198A PE68199A1 PE 68199 A1 PE68199 A1 PE 68199A1 PE 1998000281 A PE1998000281 A PE 1998000281A PE 00028198 A PE00028198 A PE 00028198A PE 68199 A1 PE68199 A1 PE 68199A1
- Authority
- PE
- Peru
- Prior art keywords
- acid
- pharmaceutical composition
- salts
- gastric residence
- generating system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE a)UN PRINCIPIO ACTIVO QUE CONSISTE DE UNA BENZAMIDA O SU SAL, PARTICULARMENTE ES EL CLORHIDRATO DE TIAPRIDE, AMISULPRIDA, SULPIRIDA, O SUS SALES, O SUS ENANTIOMEROS; b)UN SISTEMA GENERADOR DE CO2, COMPRENDE AL MENOS UN AGENTE GENERADOR DE CO2 Y AL MENOS UN COMPUESTO ACIDO ELEGIDO ENTRE ACIDO MONO Y POLICARBOXILICOS; DE PREFERENCIA ES EL ACIDO TARTARICO, SUCCINICO, CITRICO O SUS SALES; c)UN MEDIO QUE PERMITE LA RETENCION PARCIAL DE CO2 GENERADO POR DICHO SISTEMA GENERADOR DE CO2, QUE CONSISTE AL MENOS DE UN POLIMERO HIDROFILICO EL CUAL ES UN DERIVADO CELULOSICO, EN PARTICULAR HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA. TAMBIEN SE CARACTERIZA PORQUE SE PRESENTA EN FORMA DE UN COMPRIMIDO FLOTANTE. LA COMPOSICION MEJORA LA BIODISPONIBILIDAD DE LAS BENZAMIDAS POR VIA ORAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704803A FR2762213B1 (fr) | 1997-04-18 | 1997-04-18 | Composition pharmaceutique a retention gastrique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE68199A1 true PE68199A1 (es) | 1999-07-15 |
Family
ID=9506077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000281A PE68199A1 (es) | 1997-04-18 | 1998-04-17 | Composicion farmaceutica de residencia gastrica |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0983065A1 (es) |
| JP (1) | JP2001523241A (es) |
| KR (1) | KR20010006353A (es) |
| CN (1) | CN1252720A (es) |
| AR (1) | AR015586A1 (es) |
| AU (1) | AU737634B2 (es) |
| CA (1) | CA2286081A1 (es) |
| FR (1) | FR2762213B1 (es) |
| HU (1) | HUP0002455A3 (es) |
| IL (1) | IL131995A0 (es) |
| JO (1) | JO2017B1 (es) |
| MA (1) | MA26482A1 (es) |
| NO (1) | NO995039L (es) |
| NZ (1) | NZ500288A (es) |
| PE (1) | PE68199A1 (es) |
| PL (1) | PL336273A1 (es) |
| TN (1) | TNSN98049A1 (es) |
| WO (1) | WO1998047506A1 (es) |
| ZA (1) | ZA983258B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
| FR2784583B1 (fr) | 1998-10-16 | 2002-01-25 | Synthelabo | Composition pharmaceutique a residence gastrique et a liberation controlee |
| FR2790388B1 (fr) * | 1999-03-04 | 2001-04-13 | Synthelabo | Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption |
| EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| WO2009157711A2 (ko) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | 위장체류형 다공성 정제 및 그의 제조 방법 |
| FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
| HUE025008T2 (en) | 2012-10-12 | 2016-04-28 | Omya Int Ag | Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate |
| CA3084953A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| MX2020005517A (es) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Formas cristalinas y metodos de produccion de las mismas. |
| JP7044649B2 (ja) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | 胃内浮遊錠剤 |
| SG11202113266YA (en) | 2019-06-04 | 2021-12-30 | Sunovion Pharmaceuticals Inc | Modified release formulations and uses thereof |
| WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2415099A1 (fr) * | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
| FR2554718B1 (fr) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
| FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
| JPS62178518A (ja) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | 新規持続性スルピリド錠剤 |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
| CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-15 NZ NZ500288A patent/NZ500288A/xx unknown
- 1998-04-15 PL PL98336273A patent/PL336273A1/xx unknown
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/hu unknown
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/ko not_active Application Discontinuation
- 1998-04-15 CN CN98804269A patent/CN1252720A/zh active Pending
- 1998-04-15 IL IL13199598A patent/IL131995A0/xx unknown
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/fr not_active Application Discontinuation
- 1998-04-15 EP EP98920623A patent/EP0983065A1/fr not_active Ceased
- 1998-04-15 JP JP54514398A patent/JP2001523241A/ja active Pending
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 CA CA002286081A patent/CA2286081A1/en not_active Abandoned
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/fr unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/es not_active Application Discontinuation
- 1998-04-17 AR ARP980101773A patent/AR015586A1/es unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/fr unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/xx unknown
- 1998-04-18 JO JO19982017A patent/JO2017B1/en active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1252720A (zh) | 2000-05-10 |
| IL131995A0 (en) | 2001-03-19 |
| CA2286081A1 (en) | 1998-10-29 |
| NO995039L (no) | 1999-12-17 |
| JP2001523241A (ja) | 2001-11-20 |
| PL336273A1 (en) | 2000-06-19 |
| AU737634B2 (en) | 2001-08-23 |
| AR015586A1 (es) | 2001-05-16 |
| FR2762213B1 (fr) | 1999-05-14 |
| FR2762213A1 (fr) | 1998-10-23 |
| NZ500288A (en) | 2001-03-30 |
| JO2017B1 (en) | 1999-05-15 |
| TNSN98049A1 (fr) | 2005-03-15 |
| AU7341698A (en) | 1998-11-13 |
| NO995039D0 (no) | 1999-10-15 |
| MA26482A1 (fr) | 2004-12-20 |
| ZA983258B (en) | 1998-10-19 |
| WO1998047506A1 (fr) | 1998-10-29 |
| HUP0002455A2 (hu) | 2000-12-28 |
| HUP0002455A3 (en) | 2001-01-29 |
| KR20010006353A (ko) | 2001-01-26 |
| EP0983065A1 (fr) | 2000-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199500826A2 (tr) | Multipl ünite tablet doz formu 2. | |
| PE68199A1 (es) | Composicion farmaceutica de residencia gastrica | |
| CY1107675T1 (el) | Φαρμακευτικα αλατα τραμαδολης | |
| AR042345A2 (es) | Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma | |
| MX9207263A (es) | Sistema para el suministro de una substancia activa para la liberacion sostenida. | |
| DK1390378T3 (da) | Farmaceutisk aktive uridin estere | |
| CY1108823T1 (el) | Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3 | |
| PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
| ES2133785T3 (es) | Inhibidores de metaloproteinasas. | |
| CY1107610T1 (el) | Φαρμακευτικως δραστικα παραγωγα ισοινδολινης | |
| CA2273420A1 (fr) | Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale | |
| AR030541A1 (es) | Acidos aminopropilfosfinicos, su utilizacion para la manufactura de medicamentos, y formulacion farmaceutica | |
| RU94045950A (ru) | Фармацевтический препарат и способ его приготовления | |
| ES2176106B1 (es) | Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral. | |
| AR056268A1 (es) | Tabletas que comprenden una sustancia biologicamente activa y un excipiente | |
| UY26371A1 (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen | |
| IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
| ES2174293T3 (es) | Microesferas farmaceuticas de acido valproico para la administracion oral. | |
| ATE253940T1 (de) | Stabile lösung von calcitriol zum verpacken in phiolen | |
| DK0625355T3 (da) | Tablet med forbedret biologisk tilgængelighed indeholdende dichlormethylenphosphonsyre som virksomt stof | |
| DK72289D0 (da) | Cephemcarboxylsyreestere, deres fremstilling og anvendelse | |
| ES2072647T3 (es) | Composiciones que contienen sales de ranitidina/carboxilato de bismuto. | |
| BR9608255A (pt) | Sistema terapéutico transdérmico (stt) para a administração de testosterona | |
| TR199801082T2 (xx) | Fosfonokarbiksilik asitlerin yeni fosfolipid t�revleri, bunlar�n �retimi, bunun yan�s�ra bunlar�n antiviral farmas�tik maddeler olarak kullan�m�. | |
| AR004503A1 (es) | Uso de l-carnitina, l-carnitinas acilicas en las cuales el gruo acilo, lineal o ramificado, tiene entre 2 y 6 atomos de carbono y sus salesfarmaceuticamente aceptables, y composiciones farmaceuticas que comprenden tales compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |